Tikva Allocell: Funding, Investors & Team (Sep 2026)
Tikva Allocell is a biotechnology company that specializes in next-gen cell therapies.
Tikva Allocell has raised $8.0M across 1 funding round on record, the most recent a Series A of $8.0M announced in Jul 2026.
That round is above the $5.0M median round size for Singapore companies tracked on FundedIQ over the last two years.
Tikva Allocell Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Tikva Allocell Funding Rounds
Tikva Allocell Investors
Tikva Allocell Founders and Leadership Team
Contact details for the Tikva Allocell team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Tikva Allocell Funding in Context
Tikva Allocell's latest round of $8.0M is above the median round in Singapore. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tikva Allocell in Biopharma and Singapore
Companies Similar to Tikva Allocell
SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth…
N&E Innovations is a med-tech company that develops antimicrobial products.
Antarctic Exchange is a decentralized platform for perpetual futures trading with blockchain-based point…
Laters.com is a flight booking platform: 650+ airlines, pay later with Klarna, Afterpay, Affirm or Zip, or by…
MemeBitcoin is a provider of a bitcoin native meme project.
fileAI is the world's only horizontal file processing agent and AI workflow automation platform, addressing…
Bioactivx is a healthcare firm that accelerates wound recovery, deliver better outcomes for conditions like…
International Payments Identity(iPiD) is a international payments addressing platform.
storify.me is a marketplace that connects indie content creators and micro influencers with brands and…
Graas is a provider of e-commerce solutions.
Founded by Jeffrey Liu and Justin Louie, Jenfi is an alternative revenue-based financing company for…
Acrab is a technology firm that develops compute infrastructure that enables autonomous AI agents to run…
Tikva Allocell Funding FAQs
What does Tikva Allocell do?
Tikva Allocell is a biotechnology company that specializes in next-gen cell therapies.
How much funding has Tikva Allocell raised?
Tikva Allocell has raised $8.0M across 1 round on record. The most recent is a Series A of $8.0M announced in Jul 2026.
When did Tikva Allocell last raise funding?
Tikva Allocell's most recent funding round on record is a Series A of $8.0M, announced in Jul 2026.
Who has invested in Tikva Allocell?
Investors on record for Tikva Allocell include Kantharos Capital.
Who founded Tikva Allocell?
FundedIQ lists Ari Loren (Chief Operating Officer and Co-Founder) at Tikva Allocell.
Where is Tikva Allocell headquartered?
Tikva Allocell is based in Singapore, Singapore.
How many employees does Tikva Allocell have?
Tikva Allocell is in the 11-50 employee band.
When was Tikva Allocell founded?
Tikva Allocell was founded in 2023.
About FundedIQ's Tikva Allocell Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tikva Allocell is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.